Estabrook Capital Management trimmed its holdings in shares of Eli Lilly and Company (NYSE:LLY – Free Report) by 8.4% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 8,136 shares of the company’s stock after selling 749 shares during […]